Related Experiment Video
Updated: May 19, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Current and emerging systemic treatment strategies for psoriasis
1The University of Manchester, Manchester Academic Health Science Centre, Department of Dermatology, Salford Royal Hospital (Hope), Salford, Manchester, UK.
Drugs
|September 4, 2012
Summary
Systemic therapies for psoriasis, including biologics targeting specific immune pathways and new oral small molecules, offer improved disease control. These treatments advance psoriasis management by addressing its complex inflammatory nature.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin disease significantly impacting quality of life.
- Established systemic therapies possess immunosuppressive and anti-proliferative effects.
- Advances in understanding psoriasis pathogenesis reveal genetic, cellular, and immunological targets.
Purpose of the Study:
- To review current and emerging systemic treatments for psoriasis management.
- To highlight the role of biological therapies in targeting specific pathogenic components.
- To discuss the potential of small-molecule oral preparations.
Main Methods:
- Literature review of current and emerging systemic psoriasis treatments.
- Analysis of therapeutic targets based on advancements in psoriasis pathogenesis.
- Evaluation of biological and small-molecule therapies.
Main Results:
- Biological therapies, such as tumor necrosis factor (TNF)-α and interleukin (IL)-12/-23 inhibitors, show remarkable clinical responses in severe psoriasis.
- Development of other cytokine modulators is underway.
- Small-molecule oral preparations targeting intracellular signaling pathways are emerging.
Conclusions:
- Biological therapies have transformed severe psoriasis treatment by targeting key pathogenic pathways.
- Emerging small-molecule drugs offer new avenues for psoriasis control.
- Continued research into psoriasis pathogenesis drives the development of novel systemic treatments.
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation